By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Inhibitex, Inc. 

1165 Sanctuary Parkway, Suite 400

Alpharetta  Georgia  30004  U.S.A.
Phone: 678-746-1100 Fax:



Drug Discovery

Company News
Bristol-Myers Squibb Company (BMY) Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. (INHX) 2/13/2012 6:33:20 AM
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibitex, Inc. (INHX), in Connection with the Sale of the Company to Bristol-Myers Squibb Company (BMY) 1/11/2012 6:08:27 AM
Bristol-Myers Squibb Company (BMY) to Acquire Inhibitex, Inc. (INHX) for $2.5 Billion 1/9/2012 6:53:43 AM
Inhibitex, Inc. (INHX) to Participate in the 2011 Deutsche Bank (DB) BioFEST 12/2/2011 8:41:56 AM
Inhibitex, Inc. (INHX) Reports Recent Clinical and Corporate Developments 11/29/2011 9:57:39 AM
Inhibitex, Inc. (INHX) to Participate in Four Upcoming Investor Conferences 11/9/2011 8:12:17 AM
Inhibitex, Inc. (INHX) Reports Third Quarter Financial Results and Recent Corporate Developments 11/4/2011 7:02:10 AM
Inhibitex, Inc. (INHX) to Host Conference Call to Report Third Quarter Financial Results on November 4, 2011 10/27/2011 7:42:46 AM
Inhibitex, Inc. (INHX) Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients 9/19/2011 9:41:19 AM
Inhibitex, Inc. (INHX) to Present at Two Upcoming Conferences 8/26/2011 9:43:35 AM